Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 153Neoplasms 112Carcinoma, Non-Small-Cell Lung 85Colorectal Neoplasms 81Prostatic Neoplasms 80Lung Neoplasms 73Leukemia, Myeloid, Acute 50Carcinoma, Hepatocellular 48Pancreatic Neoplasms 46Neoplasm Metastasis 40Multiple Myeloma 37Recurrence 35Triple Negative Breast Neoplasms 29Squamous Cell Carcinoma of Head and Neck 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Melanoma 27Glioblastoma 27Ovarian Neoplasms 26Brain Neoplasms 26Uterine Cervical Neoplasms 25Head and Neck Neoplasms 25Stomach Neoplasms 24Rectal Neoplasms 24Small Cell Lung Carcinoma 22Carcinoma, Renal Cell 20Lymphoma, B-Cell 19Glioma 19Lymphoma, Follicular 18Lymphoma 18Endometrial Neoplasms 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Cancer Cachexia × 90 days × Clear all
NCT07584057 2026-05-13

An Phase I/IIa Clinical Study to Evaluate the Safety/Tolerability, Pharmacokinetics and Preliminary Efficacy of INB301 Injection in Patients With Cancer Cachexia

Yunnan Baiyao Group Co., Ltd.

Phase 1/2 Not yet recruiting
146 enrolled

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡